{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34257426",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41587-021-00984-7"
    ],
    "Journal": {
      "ISSN": "1546-1696",
      "JournalIssue": {
        "Volume": "39",
        "Issue": "8",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "Nature biotechnology",
      "ISOAbbreviation": "Nat Biotechnol"
    },
    "ArticleTitle": "COVID-19 long haulers.",
    "Pagination": {
      "StartPage": "908",
      "EndPage": "913",
      "MedlinePgn": "908-913"
    },
    "Abstract": {
      "AbstractText": [
        "With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": ", Portland, ME, USA."
          }
        ],
        "LastName": "Schmidt",
        "ForeName": "Charles",
        "Initials": "C"
      }
    ],
    "PublicationTypeList": [
      "News"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Nat Biotechnol",
    "NlmUniqueID": "9604648",
    "ISSNLinking": "1087-0156"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Nat Biotechnol. 2021 Jul 26;:",
      "PMID": "34312501"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "complications",
        "physiopathology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Repositioning"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Post-Acute COVID-19 Syndrome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}